Author:
Strehl S,König M,Boztug H,Cooper B W,Suzukawa K,Zhang S-J,Chen H-Y,Attarbaschi A,Dworzak M N
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference16 articles.
1. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action ‘Molecular Cytogenetic Diagnosis in Haematological Malignancies'. Blood 2000; 96: 1297–1308.
2. Mistry AR, Pedersen EW, Solomon E, Grimwade D . The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev 2003; 17: 71–97.
3. Catalano A, Dawson MA, Somana K, Opat S, Schwarer A, Campbell LJ et al. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia. Blood 2007; 110: 4073–4076.
4. Yamamoto Y, Tsuzuki S, Tsuzuki M, Handa K, Inaguma Y, Emi N . BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Blood 2010; 116: 4274–4283.
5. Lengfelder E, Hofmann WK, Nowak D . Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia 2012; 26: 433–442.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献